中国黄褐斑诊疗专家共识（2021版）

doi:10.35541/cjd.20200900

Abstract

Abstract: 【Abstract】 At present, exact pathogenesis of melasma remains unclear, genetics, sunlight exposure, sex hormones, etc., are considered as the main causative factors. Its pathogenesis involves excessive melanin synthesis, vascular hyperplasia in skin lesions, inflammation and skin barrier impairment. The diagnosis of melasma mainly relies on clinical manifestations and non-invasive detection techniques. Based on research progress in recent years, this consensus comprehensively elaborates the etiology, pathogenesis, clinical manifestations, staging and classification, diagnosis and treatment of melasma, aiming to improve the diagnosis and treatment of melasma by Chinese dermatologists.

Key words: Melasma, Guidelines, Diagnosis, Therapy

Pigmentary Disorder Group, Combination of Traditional and Western Medicine Dermatology, Research Center for Vitiligo, Chinese Society of Dermatology, Working Group on Pigmentary Disorders, China Dermatologist Association. Consensus on diagnosis and treatment of melasma in China （2021 version）[J]. Chinese Journal of Dermatology, 2021, 54(2): 110-115.doi:10.35541/cjd.20200900

References ［39］

［1］	Passeron T, Picardo M. Melasma, a photoaging disorder［J］. Pigment Cell Melanoma Res, 2018,31（4）:461⁃465. doi: 10.1111/pcmr.12684.
［2］	中国中西医结合学会皮肤性病专业委员会色素病学组, 中华医学会皮肤性病学分会白癜风研究中心, 中国医师协会皮肤科医师分会色素病工作组. 中国黄褐斑治疗专家共识（2015）［J］. 中华皮肤科杂志, 2016,49（8）:529⁃532. doi: 10.3760/cma.j.issn.0412⁃4030.2016.08.001.
［3］	Kim EH, Kim YC, Lee ES, et al. The vascular characteristics of melasma［J］. J Dermatol Sci, 2007,46（2）:111⁃116. doi: 10.1016/j.jdermsci.2007.01.009.
［4］	Tamega Ade A, Miot LD, Bonfietti C, et al. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women［J］. J Eur Acad Dermatol Venereol, 2013,27（2）:151⁃156. doi: 10.1111/j.1468⁃3083.2011.04430.x.
［5］	Handel AC, Lima PB, Tonolli VM, et al. Risk factors for facial melasma in women: a case⁃control study［J］. Br J Dermatol, 2014,171（3）:588⁃594. doi: 10.1111/bjd.13059.
［6］	Hexsel D, Arellano I, Rendon M. Ethnic considerations in the treatment of Hispanic and Latin⁃American patients with hyperpigmentation［J］. Br J Dermatol, 2006,156（Suppl 1）:7⁃12. doi: 10.1111/j.1365⁃2133.2006.07589.x.
［7］	Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long⁃wavelength UVA and visible light on melanocompetent skin［J］. J Invest Dermatol, 2010,130（8）:2092⁃2097. doi: 10.1038/jid. 2010.95.
［8］	KrupaShankar DS, Somani VK, Kohli M, et al. A cross⁃sectional, multicentric clinico⁃epidemiological study of melasma in India［J］. Dermatol Ther （Heidelb）, 2014,4（1）:71⁃81. doi: 10.1007/s13555⁃014⁃0046⁃1.
［9］	Noh TK, Choi SJ, Chung BY, et al. Inflammatory features of melasma lesions in Asian skin［J］. J Dermatol, 2014,41（9）:788⁃794. doi: 10.1111/1346⁃8138.12573.
［10］	Rodríguez⁃Arámbula A, Torres⁃Álvarez B, Cortés⁃García D, et al. CD4, IL⁃17, and COX⁃2 are associated with subclinical inflammation in malar melasma［J］. Am J Dermatopathol, 2015,37（10）:761⁃766. doi: 10.1097/DAD.0000000000000378.
［11］	Lee DJ, Lee J, Ha J, et al. Defective barrier function in melasma skin［J］. J Eur Acad Dermatol Venereol, 2012,26（12）:1533⁃1537. doi: 10.1111/j.1468⁃3083.2011.04337.x.
［12］	Li Y, Yang CY, Man MQ, et al. Disruption of epidermal permeability barrier enhances UV⁃induced hyperpigmentation［J］. Photodermatol Photoimmunol Photomed, 2020,36（2）:156⁃158. doi: 10.1111/phpp.12515.
［13］	Sarkar R, Jagadeesan S, Basavapura Madegowda S, et al. Clinical and epidemiologic features of melasma: a multicentric cross⁃sectional study from India［J］. Int J Dermatol, 2019,58（11）:1305⁃1310. doi: 10.1111/ijd.14541.
［14］	张琼予, 孙东杰, 涂颖, 等. 黄褐斑的临床分期［J］. 中华医学美学美容杂志, 2018,24（4）:274⁃278. doi: 10.3760/cma.j.issn. 1671⁃0290.2018.04.017.
［15］	陈荣, 许爱娥. 不同时期黄褐斑皮损三种皮肤影像的形态学分析［J］. 中华皮肤科杂志, 2019,52（2）:103⁃106. doi: 10.3760/cma.j.issn.0412⁃4030.2019.02.007.
［16］	Liu H, Lin Y, Nie X, et al. Histological classification of melasma with reflectance confocal microscopy: a pilot study in Chinese patients［J］. Skin Res Technol, 2011,17（4）:398⁃403. doi: 10. 1111/j.1600⁃0846.2011.00517.x.
［17］	朱丽萍, 庞勤, 吕乐春, 等. 黄褐斑患者组织病理特征分析［J］. 中华皮肤科杂志, 2016,49（10）:706⁃711. doi: 10.3760/cma. j.issn.0412⁃4030.2016.10.006.
［18］	Lu Q, Yang C, Wu J, et al. Confocal laser scanning microscopy, a diagnostic alternative for five pigmented lesions on the face: an observational study［J］. Skin Res Technol, 2019,25（6）:871⁃876. doi: 10.1111/srt.12749.
［19］	黄骏, 许爱娥. 反射式共聚焦显微镜和皮肤镜在评估黑变病综合疗法效果中的应用［J］. 中华皮肤科杂志, 2018,51（6）:440⁃442. doi: 10.3760/cma.j.issn.0412⁃4030.2018.06.010.
［20］	Pandya A, Berneburg M, Ortonne JP, et al. Guidelines for clinical trials in melasma. Pigmentation Disorders Academy［J］. Br J Dermatol, 2006,156（Suppl 1）:21⁃28. doi: 10.1111/j.1365⁃2133.2006.07590.x.
［21］	黄骏, 许爱娥. 反射式共聚焦显微镜联合皮肤镜在黄褐斑皮损黑素与血管评估中的应用［J］. 中华皮肤科杂志, 2016,49（8）:591⁃594. doi: 10.3760/cma.j.issn.0412⁃4030.2016.08.015.
［22］	舒敏保湿类护肤品在敏感性皮肤中应用指南专家组. 舒敏保湿类护肤品在敏感性皮肤中的应用指南［J］. 中国皮肤性病学杂志, 2019,33（11）:1229⁃1231. doi: 10.13735/j.cjdv.1001⁃7089.201910016.
［23］	涂颖, 顾华, 李娜, 等. 青刺果油对神经酰胺合成及神经酰胺酶表达的影响［J］. 中华皮肤科杂志, 2012,45（10）:718⁃722. doi: 10.3760/cma.j.issn.0412⁃4030.2012.10.012.
［24］	Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial［J］. J Am Acad Dermatol, 2015,72（1）:189⁃190.e1. doi: 10.1016/j.jaad.2014.08.023.
［25］	Zhong SM, Sun N, Liu HX, et al. Reduction of facial pigmentation of melasma by topical lignin peroxidase: a novel fast⁃acting skin⁃lightening agent［J］. Exp Ther Med, 2015,9（2）:341⁃344. doi: 10.3892/etm.2014.2118.
［26］	Zhang Q, Tu Y, Gu H, et al. A cream of herbal mixture to improve melasma［J］. J Cosmet Dermatol, 2019,18（6）:1721⁃1728. doi: 10.1111/jocd.12938.
［27］	Na JI, Choi SY, Yang SH, et al. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation［J］. J Eur Acad Dermatol Venereol, 2013,27（8）:1035⁃1039. doi: 10.1111/j.1468⁃3083.2012.04464.x.
［28］	黄骏, 胡文婷, 章玲玲, 等. 复方甘草酸苷注射液治疗黄褐斑疗效评估［J］. 中华皮肤科杂志, 2018,51（4）:299⁃301. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.012.
［29］	Handog EB, Galang DA, de Leon⁃Godinez MA, et al. A randomized, double⁃blind, placebo⁃controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women［J］. Int J Dermatol, 2009,48（8）:896⁃901. doi: 10.1111/j.1365⁃4632.2009.04130.x.
［30］	Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: facts, myths, evidence and controversies［J］. Indian J Dermatol Venereol Leprol, 2016,82（3）:262⁃272. doi: 10.4103/0378⁃6323.179088.
［31］	Rodrigues M, Pandya AG. Melasma: clinical diagnosis and management options［J］. Australas J Dermatol, 2015,56（3）:151⁃163. doi: 10.1111/ajd.12290.
［32］	Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence⁃based review［J］. Am J Clin Dermatol, 2013,14（5）:359⁃376. doi: 10.1007/s40257⁃013⁃0038⁃4.
［33］	Hu ZM, Zhou Q, Lei TC, et al. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: biosafety as skin whitening agents［J］. J Dermatol Sci, 2009,55（3）:179⁃184. doi: 10.1016/j.jdermsci.2009.06.003.
［34］	Kim SJ, Park JY, Shibata T, et al. Efficacy and possible mechanisms of topical tranexamic acid in melasma［J］. Clin Exp Dermatol, 2016,41（5）:480⁃485. doi: 10.1111/ced.12835.
［35］	中华医学会皮肤性病学分会皮肤美容学组. 果酸化学剥脱术临床应用专家共识［J］. 中华皮肤科杂志, 2014,47（10）:748⁃749. doi: 10.3760/cma.j.issn.0412⁃4030.2014.10.023.
［36］	栾琪, 刘玲, 高天文. 激光和强脉冲光治疗黄褐斑的进展［J］. 中华皮肤科杂志, 2015,48（2）:142⁃143. doi: 10.3760/cma.j.issn.0412⁃4030.2015.02.023.
［37］	Choi JE, Lee DW, Seo SH, et al. Low⁃fluence Q⁃switched Nd:YAG laser for the treatment of melasma in Asian patients［J］. J Cosmet Dermatol, 2018,17（6）:1053⁃1058. doi: 10.1111/jocd.12 760.
［38］	Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma［J］. Int J Womens Dermatol, 2017,3（1）:11⁃20. doi: 10.1016/j.ijwd.2017.01.004.
［39］	中华中医药学会皮肤科分会, 中国医师协会皮肤科医师分会中西医结合专业委员会. 黄褐斑中医治疗专家共识［J］. 中国中西医结合皮肤性病学杂志, 2019,18（4）:372⁃374. doi: 10. 3969/j.issn.1672⁃0709.2019.04.031.

[1]	Zhang Ning, Li Shu, Li Jing . Efficacy of immune checkpoint inhibitors and targeted therapy in adjuvant treatment of resectable melanoma: a network meta-analysis [J]. Chinese Journal of Dermatology, 2022, 0(4): 20200767-e20200767.
[2]	Lyu Ling, Lyu Xiaoyan. Dermatomyositis with malignancy: an update [J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279.
[3]	Li Suo, Xiang Ruiyu, Li Zhiliang, Jing Ke, Wang Yuan, Zhang Hanmei, Feng Suying. Evaluation of the value of indirect immunofluorescence on salt-split skin in the diagnosis of bullous pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(3): 235-237.
[4]	Liu Yuzhen, Zeng Rong, Zheng Nana, Duan Zhimin, Xu Haoxiang, Wu Qiuju, Lin Tong, Li Min. Effect of different incubation time of aminolevulinic acid on photodynamic inhibition of Propionibacterium acnes biofilms [J]. Chinese Journal of Dermatology, 2022, 55(3): 208-212.
[5]	Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2022） [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195.
[6]	Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong. A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210694-e20210694.
[7]	Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184.
[8]	Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong. A comparative study of human immunoglobulin versus recombinant human tumor necrosis factor-α receptor Ⅱ:IgG Fc fusion protein in the treatment of toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2022, 55(2): 153-156.
[9]	Jiao Xiaoyan, Yin Guangwen, Yin Yakun, Li Dongqin. Clinical analysis of 25 cases of herpes zoster during pregnancy or the perinatal period [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210384-e20210384.
[10]	Li Sai, Xue Huazhong, Zhang Shuwen, Jiang Juan, Qi Shuzhen, Zhao Yuanyuan, Zhang Jinping, Sha Zhong, Le Wenjing, Wang Biwei, Zhao Shixuan, Zhu Xiaofeng, Su Xiaohong. Doxycycline-moxifloxacin sequential therapy for Mycoplasma genitalium urethritis/cervicitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210631-e20210631.
[11]	Cheng Bihong, Dou Xia. Diagnosis and classification of chronic prurigo [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210130-e20210130.
[12]	Wang Yuan, Yu Meiwen, Xiang Ruiyu, Li Suo, Li Zhiliang, Jin Ke, Zhang Hanmei, Feng Suying. Optimization of indirect immunofluorescence on salt-split skin and its application in detection of bullous pemphigoid antibodies [J]. Chinese Journal of Dermatology, 2022, 55(1): 12-15.
[13]	Zhang Ying, Gan Lu, Li Siqi, Li Yan, Song Hao, Shao Xuebao, Zhang Wei, Xu Xiulian, Jiang Yiqun, Zeng Xuesi, Chen Hao, Sun Jianfang. Clinicopathological and immunophenotypic analysis of 24 cases of transformed mycosis fungoides [J]. Chinese Journal of Dermatology, 2022, 55(1): 20-26.
[14]	Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases （2022） [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11.
[15]	Luan Chao, Hu Yu, Chen Kun, Zhang Jiaan, Gu Heng, Zhang Ronglin, Zhang Xiaohua, Tian Panpan, Zhu Yan, Zhuang Chen, Huang Dan, Ju Mei. Efficacy and safety of 308-nm SQ light-emitting diode light and 308-nm excimer light in the treatment of facial vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(1): 16-19.

Consensus on diagnosis and treatment of melasma in China （2021 version）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［39］

Related Articles 15

Metrics

Comments

Recommended 10